Now on Android. Existing accounts work. Get it on Google Play.

Spironolactone (Aldactone): nursing considerations

Spironolactone is a potassium-sparing diuretic: it makes the kidneys get rid of sodium and water but keep potassium. It can cause hyperkalemia. Kidney problems, potassium supplements, salt substitutes, and ACE inhibitors or angiotensin receptor blockers (ARBs) make hyperkalemia more likely. Check potassium within 1 week of starting or changing the dose, then regularly.⁠[1][2]

Start monthly 5-day trial

Payment method required. First-time subscribers only. After the trial, the plan costs $19.99/month until you cancel. You aren't charged if you cancel before the trial ends. Cancel anytime online.

Quick facts

Spironolactone at a glance
FactSpironolactone
Drug class⁠[1][2]Potassium-sparing diuretic; aldosterone antagonist (it blocks aldosterone in the kidney)
Used for⁠[1]Heart failure with reduced ejection fraction (New York Heart Association, NYHA, class III to IV); add-on treatment for high blood pressure; edema from cirrhosis or nephrotic syndrome; primary hyperaldosteronism (too much aldosterone)
Contraindicated with⁠[1]Hyperkalemia, Addison's disease, or taking eplerenone
Check⁠[1]Potassium within 1 week of starting or a dose change, then regularly; fluid status and kidney function; electrolytes, uric acid, and glucose
Raise potassium further⁠[1]Potassium supplements, salt substitutes, ACE inhibitors, angiotensin receptor blockers (ARBs), nonsteroidal anti-inflammatory drugs (NSAIDs), heparin, and trimethoprim
Other effects⁠[1]Breast enlargement (gynecomastia), usually reversible; low sodium, magnesium, or calcium; high glucose and uric acid

Before giving spironolactone: potassium and kidney function

  • Check the potassium. Hyperkalemia is more likely when kidney function is poor or the patient also takes potassium supplements, potassium salt substitutes, ACE inhibitors, or ARBs.⁠[1]
  • Potassium may need checking more often in a patient with kidney impairment or taking other drugs that raise potassium.⁠[1]
  • If the potassium is high, the dose is lowered or the drug is stopped and the hyperkalemia is treated, so report a high result.⁠[1]
  • In heart failure, potassium supplements are generally stopped when spironolactone starts.⁠[1]
  • Too much diuresis can cause dehydration, low blood pressure, and worse kidney function, especially in a patient low on salt or taking ACE inhibitors or ARBs, so watch fluid status and kidney function.⁠[1]
  • Report urine output below 30 mL/hour.⁠[2]

Other warnings: electrolytes, breast enlargement, liver disease, lithium, and pregnancy

  • It can also lower sodium, magnesium, and calcium, cause low chloride with a raised blood pH (hypochloremic alkalosis), and raise blood glucose and uric acid, so electrolytes, uric acid, and glucose are checked from time to time.⁠[1]
  • Breast enlargement (gynecomastia) developed in about 9% of men taking it for heart failure in the RALES trial. The risk rises with the dose, it can appear anywhere from 1 to 2 months to more than a year after starting, and it is usually reversible.⁠[1]
  • In cirrhosis with ascites, sudden fluid and electrolyte shifts can worsen hepatic encephalopathy, so it is started in the hospital.⁠[1]
  • It slows how fast the kidneys clear lithium, which raises the risk of lithium toxicity, so lithium levels are checked periodically.⁠[1]
  • It falsely raises the result of some digoxin blood tests, so a patient who takes both needs a test method it doesn't affect.⁠[1]
  • In pregnancy it is avoided, or the patient is told about the possible risk to a male fetus, because it blocks the effects of male sex hormones.⁠[1]

Teach the patient to avoid salt substitutes and high-potassium foods

  • Avoid potassium supplements, salt substitutes, and foods high in potassium.⁠[1][2]
  • Take it in the morning to avoid getting up at night to urinate, at the same time each day, and report big weight changes.⁠[2]
  • It can be taken with or without food, but the same way each time.⁠[1]
  • Change positions slowly, because diuretics can make blood pressure drop on standing.⁠[2]

Spironolactone appears in MagstoneRN's Bowtie, Matrix, and select-all-that-apply pharmacology practice, and the app's clinical tools include a drug reference for it.

Browse clinical tools

How it shows up on nursing exams

  • In the distal tubule, aldosterone makes the kidneys hold on to sodium and let potassium go. Spironolactone blocks aldosterone there, so sodium and water leave and potassium stays.⁠[1][2]
  • Because it keeps potassium, an ACE inhibitor, an ARB, or a potassium supplement given with it makes hyperkalemia more likely.⁠[1]
  • For the same reason, it can help with edema when another diuretic has caused hypokalemia.⁠[1]

Practice question

A patient with heart failure who takes lisinopril started spironolactone 5 days ago. The laboratory reference range for potassium is 3.5 to 5.1 mEq/L. Which finding should the nurse report to the health care provider first?

  1. A. Blood pressure 118/72 mm Hg
  2. B. Urine output 45 mL/hour
  3. C. Serum potassium 5.8 mEq/L
  4. D. Weight down 1 pound since yesterday
Show the answer and why

Correct answer: C. Serum potassium 5.8 mEq/L

  • A. Incorrect. Lowering blood pressure is one of spironolactone's intended effects, and this reading is not low enough to report first.
  • B. Incorrect. Urine output is reported when it falls below 30 mL/hour. 45 mL/hour is above that.
  • C. Correct. 5.8 mEq/L is above the range. Spironolactone can cause hyperkalemia, and an ACE inhibitor such as lisinopril makes it more likely. A high potassium means a lower dose or stopping the drug, so this is reported first.
  • D. Incorrect. A small weight loss fits the intended diuresis. It does not outrank a high potassium.

Sources for this question: ⁠[1][2][3]

Memory hook: Spironolactone spares potassium: no salt substitutes, no extra potassium, and keep an eye on the potassium level.

Questions about spironolactone

Why check potassium with spironolactone?

It makes the kidneys keep potassium, so it can cause hyperkalemia. Potassium is checked within 1 week of starting or changing the dose and regularly after that.⁠[1][2]

Can spironolactone be given with lisinopril?

Yes, but both can raise potassium (lisinopril is an ACE inhibitor), so hyperkalemia is more likely. Potassium is checked again whenever the ACE inhibitor or ARB is changed.⁠[1][4]

Does spironolactone cause breast enlargement?

It can. About 9% of men in the RALES heart failure trial developed breast enlargement (gynecomastia). The risk rises with the dose, and it is usually reversible.⁠[1]

Study this topic in MagstoneRN

Browse the pharmacology decks, practice question types, and clinical tools in the free app preview.

Open the free app preview
Start monthly 5-day trial

Payment method required. First-time subscribers only. After the trial, the plan costs $19.99/month until you cancel. You aren't charged if you cancel before the trial ends. Cancel anytime online.

MagstoneRN plans and trial terms

Sources for this page

All 4 sources
  1. ALDACTONE (spironolactone) tablets, prescribing information (DailyMed version 25, November 28, 2025) (opens in a new tab). Pfizer Laboratories Div Pfizer Inc, on DailyMed (National Library of Medicine). License: U.S. drug label published on DailyMed; facts cited, no text reused. Accessed November 13, 2026.
  2. Nursing Pharmacology, 2nd edition, Chapter 6: Cardiovascular & Renal Systems (opens in a new tab). Open RN, Chippewa Valley Technical College (2023). License: CC BY 4.0. Accessed October 18, 2026.
  3. Potassium, default method (reference interval effective September 14, 2026) (opens in a new tab). UW Medicine Laboratory Test Guide. License: Not openly licensed; reference values cited as facts, no text reused. Accessed October 18, 2026.
  4. ZESTRIL (lisinopril) tablets, prescribing information (DailyMed version 2, January 2, 2025) (opens in a new tab). Upsher-Smith Laboratories, on DailyMed (National Library of Medicine). License: U.S. drug label published on DailyMed; facts cited, no text reused. Accessed October 18, 2026.

MagstoneRN wrote this page from the sources listed here. MagstoneRN has not commissioned an independent clinical review of it.

A number in brackets links to the source for the fact it follows. How we source our content explains where the facts come from, and the educational use terms explain what study pages like this one are for.

Report a wrong or outdated fact through support so MagstoneRN can correct the page.

Sources: 4 entries, from FDA drug labels and reputable secondary sources, last accessed November 13, 2026.